Aditxt (ADTX) Competitors $1.16 -0.01 (-0.86%) As of 10:52 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ADTX vs. TLPH, LSB, AEON, DWTX, JBIO, CHRO, CLRB, BMRA, KPRX, and TSBXShould you be buying Aditxt stock or one of its competitors? The main competitors of Aditxt include Talphera (TLPH), LakeShore Biopharma (LSB), AEON Biopharma (AEON), Dogwood Therapeutics (DWTX), Jade Biosciences (JBIO), Chromocell Therapeutics (CHRO), Cellectar Biosciences (CLRB), Biomerica (BMRA), Kiora Pharmaceuticals (KPRX), and Turnstone Biologics (TSBX). These companies are all part of the "pharmaceutical products" industry. Aditxt vs. Its Competitors Talphera LakeShore Biopharma AEON Biopharma Dogwood Therapeutics Jade Biosciences Chromocell Therapeutics Cellectar Biosciences Biomerica Kiora Pharmaceuticals Turnstone Biologics Talphera (NASDAQ:TLPH) and Aditxt (NASDAQ:ADTX) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, institutional ownership, risk, profitability and earnings. Does the media favor TLPH or ADTX? In the previous week, Aditxt had 2 more articles in the media than Talphera. MarketBeat recorded 3 mentions for Aditxt and 1 mentions for Talphera. Talphera's average media sentiment score of 1.89 beat Aditxt's score of 0.76 indicating that Talphera is being referred to more favorably in the media. Company Overall Sentiment Talphera Very Positive Aditxt Positive Is TLPH or ADTX more profitable? Talphera has a net margin of 0.00% compared to Aditxt's net margin of -46,082.47%. Talphera's return on equity of -130.28% beat Aditxt's return on equity.Company Net Margins Return on Equity Return on Assets TalpheraN/A -130.28% -59.25% Aditxt -46,082.47%-389.10%-84.71% Which has more risk & volatility, TLPH or ADTX? Talphera has a beta of -0.11, indicating that its stock price is 111% less volatile than the S&P 500. Comparatively, Aditxt has a beta of 1.49, indicating that its stock price is 49% more volatile than the S&P 500. Which has higher valuation & earnings, TLPH or ADTX? Talphera has higher revenue and earnings than Aditxt. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTalphera$650K13.06-$13M-$0.45-0.92Aditxt$55.32K44.26-$34.45MN/AN/A Do insiders & institutionals believe in TLPH or ADTX? 37.7% of Talphera shares are owned by institutional investors. Comparatively, 15.5% of Aditxt shares are owned by institutional investors. 3.2% of Talphera shares are owned by insiders. Comparatively, 0.0% of Aditxt shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Do analysts recommend TLPH or ADTX? Talphera currently has a consensus price target of $5.00, indicating a potential upside of 1,107.73%. Given Talphera's stronger consensus rating and higher probable upside, analysts clearly believe Talphera is more favorable than Aditxt.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Talphera 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 3.50Aditxt 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryTalphera beats Aditxt on 12 of the 15 factors compared between the two stocks. Get Aditxt News Delivered to You Automatically Sign up to receive the latest news and ratings for ADTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ADTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ADTX vs. The Competition Export to ExcelMetricAditxtMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.45M$2.43B$5.56B$9.28BDividend YieldN/A1.79%4.23%4.03%P/E RatioN/A9.2128.6419.62Price / Sales44.26691.60430.8295.68Price / CashN/A164.3436.0257.93Price / Book-0.764.648.155.59Net Income-$34.45M$30.99M$3.24B$257.73M7 Day Performance-4.55%0.13%-0.64%-0.23%1 Month Performance-16.30%7.35%4.92%7.98%1 Year Performance-99.99%-6.60%25.99%13.16% Aditxt Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ADTXAditxtN/A$1.16-0.9%N/A-100.0%$2.45M$55.32K0.0060News CoverageGap DownTLPHTalphera2.3684 of 5 stars$0.46+2.7%$5.00+979.9%-52.5%$9.49M$650K-1.0319LSBLakeShore Biopharma0.7237 of 5 stars$0.99-0.4%N/A-76.1%$9.22M$672.27M0.00773Gap DownAEONAEON Biopharma2.4121 of 5 stars$0.79-5.5%$360.00+45,371.8%-99.5%$8.95MN/A4.405DWTXDogwood Therapeutics1.8774 of 5 stars$4.60-4.2%$10.00+117.4%N/A$8.79MN/A-0.255JBIOJade Biosciences2.2888 of 5 stars$10.45-6.2%$14.00+34.0%N/A$8.78MN/A-0.1820Analyst ForecastCHROChromocell TherapeuticsN/A$1.34+6.3%N/A-88.5%$8.69MN/A-1.084Gap UpHigh Trading VolumeCLRBCellectar Biosciences2.5398 of 5 stars$4.80flat$375.00+7,712.5%-93.8%$8.69MN/A-0.2210Positive NewsBMRABiomerica1.4977 of 5 stars$3.40+4.0%N/A+4.3%$8.67M$5.41M-1.4760KPRXKiora Pharmaceuticals3.1737 of 5 stars$2.81-1.4%$10.00+255.9%-27.9%$8.54M$16.02M-0.9710TSBXTurnstone Biologics3.3932 of 5 stars$0.37+0.9%$0.45+23.3%-85.8%$8.45M$19.31M-0.1382 Related Companies and Tools Related Companies Talphera Alternatives LakeShore Biopharma Alternatives AEON Biopharma Alternatives Dogwood Therapeutics Alternatives Jade Biosciences Alternatives Chromocell Therapeutics Alternatives Cellectar Biosciences Alternatives Biomerica Alternatives Kiora Pharmaceuticals Alternatives Turnstone Biologics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ADTX) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredCentral Banks Are Hoarding Gold – Should You?The AI boom isn’t just transforming technology—it’s redefining global power, increasing government debt, and u...Lear Capital | SponsoredMajor Rollout of Social Security X?To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe Next Commodity Crisis Just Got a Name: SilverElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aditxt, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aditxt With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.